Brabourne Enterprises Ltd(merged)
- Market Cap ₹ Cr.
- Current Price ₹ 10.0
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE -0.08 %
- ROE -7.81 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of 8.70% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | |
|---|---|---|---|
| 146 | 121 | 0 | |
| 107 | 99 | 29 | |
| Operating Profit | 39 | 22 | -29 |
| OPM % | 27% | 18% | |
| 4 | 4 | 2 | |
| Interest | 15 | 11 | 0 |
| Depreciation | 6 | 5 | 0 |
| Profit before tax | 22 | 10 | -27 |
| Tax % | 12% | 17% | 11% |
| 20 | 8 | -30 | |
| EPS in Rs | |||
| Dividend Payout % | 18% | 26% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -173% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 9% |
| Last Year: | -8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | |
|---|---|---|---|
| Equity Capital | 14 | 14 | 14 |
| Reserves | 72 | 77 | 48 |
| 94 | 84 | 0 | |
| 59 | 43 | 1 | |
| Total Liabilities | 239 | 218 | 63 |
| 30 | 26 | 1 | |
| CWIP | 0 | 12 | 0 |
| Investments | 37 | 33 | 53 |
| 173 | 148 | 10 | |
| Total Assets | 239 | 218 | 63 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | |
|---|---|---|---|
| 44 | 15 | 0 | |
| -9 | -8 | 0 | |
| -9 | -26 | -3 | |
| Net Cash Flow | 27 | -19 | -2 |
| Free Cash Flow | 40 | 2 | 0 |
| CFO/OP | 128% | 70% | -1% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | |
|---|---|---|---|
| Debtor Days | 64 | 74 | |
| Inventory Days | 183 | 168 | |
| Days Payable | 297 | 269 | |
| Cash Conversion Cycle | -51 | -28 | |
| Working Capital Days | 209 | 282 | |
| ROCE % | 12% | -0% |
Documents
Announcements
No data available.
Annual reports
No data available.